Chlorambucil in Indolent Chronic Lymphocytic Leukemia
Open Access
- 21 May 1998
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 338 (21) , 1506-1514
- https://doi.org/10.1056/nejm199805213382104
Abstract
To determine whether chlorambucil treatment benefits patients with indolent chronic lymphocytic leukemia (CLL), we conducted two randomized trials in 1535 patients with previously untreated stage A CLL.Keywords
This publication has 25 references indexed in Scilit:
- Chlorambucil in Chronic Lymphocytic Leukemia: Mechanism of ActionLeukemia & Lymphoma, 1996
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995
- Is the CHOP Regimen a Good Treatment for Advanced CLL? Results from two Randomized Clinical TrialsLeukemia & Lymphoma, 1994
- CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3Leukemia & Lymphoma, 1991
- THE ONCOGENICITY OF CHLORAMBUCIL IN RHEUMATOID ARTHRITISRheumatology, 1988
- Treatment of early chronic lymphocytic leukemia: Intermittent chlorambucil versus observationHematological Oncology, 1988
- Malignancies induced by chlorambucilCancer Treatment Reviews, 1984
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958